基因进步如何转化为改善遗传出血障碍患者的诊断结果
Megan Chaigneau1, Mackenzie Bowman1, Andrea Guerin2
1Department of Medicine, Queen's University, Kingston, ON, Canada.
Blood vessels, thrombosis & hemostasis
|September 22, 2025
概括
基因检测为遗传性出血障碍的长期诊断旅程提供了一个有希望的解决方案. 测序技术的进步和社区投资是改善这些罕见疾病诊断结果的关键.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 遗传性出血障碍是一个诊断挑战,许多患者仍未被诊断出来.
- 诊断的旅程往往是漫长的,昂贵的,并且在情感上是累人的.
研究的目的:
- 审查使得使用遗传进步在诊断出血障碍的因素.
- 确定基因和基因组测试整合和变种分类的改进领域.
主要方法:
- 关于遗传性出血疾病遗传检测的文献综述.
- 对促进诊断改进的因素的分析.
- 识别当前诊断途径中的挑战和机遇.
主要成果:
- 早期对血友病的成功,测序技术的进步和社区投资推动了进展.
- 遗传/基因组测试和变种分类的整合需要优化.
- 偶然和次要的发现既带来了挑战,也带来了机会.
结论:
- 基因检测对于改善遗传性出血障碍诊断结果至关重要.
- 需要进一步的研究和战略整合来克服剩余的诊断障碍.
- 重新评估偶然发现的作用对于全面的患者护理至关重要.
更多相关视频
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.7K
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
12.9K
相关概念视频
01:22Bone Marrow Sampling and Transplants
899
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
899
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K